Search Results for: THBS1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
MMP9 matrix metallopeptidase 9
  • Signaling by SCF-KIT
  • Collagen degradation
  • Collagen degradation
  • Degradation of the extracellular matrix
  • Degradation of the extracellular matrix
  • Activation of Matrix Metalloproteinases
  • Assembly of collagen fibrils and other multimeric structures
  • EPH-ephrin mediated repulsion of cells
  • Interleukin-4 and Interleukin-13 signaling
  • Neutrophil degranulation
  • Extra-nuclear estrogen signaling
  • Glutathione
  • Marimastat
  • Minocycline
  • Captopril
  • Zinc
  • 2-Amino-N,3,3-Trimethylbutanamide
  • 2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid
  • AE-941
  • PG-530742
  • Endostatin
  • 5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE
  • (2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE
  • (3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID
  • Oleandrin
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
  • Penile cancer
  • Metaphyseal dysplasias, including: Metaphyseal dysplasia, Schmid type; Metaphyseal dysplasia, McKusik type; Metaphyseal dysplasia, Jansen type; Shwachman-Bodian-Diamond syndrome (SBDS); Metaphyseal anadysplasia (MAD)
MTDH metadherin
PDGFB platelet derived growth factor subunit B
  • Platelet degranulation
  • PIP3 activates AKT signaling
  • Downstream signal transduction
  • Signaling by PDGF
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • Non-integrin membrane-ECM interactions
  • RAF/MAP kinase cascade
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • Pegpleranib
  • Glioma
  • Malignant pleural mesothelioma
PLG plasminogen
  • Platelet degranulation
  • Degradation of the extracellular matrix
  • Degradation of the extracellular matrix
  • Activation of Matrix Metalloproteinases
  • Signaling by PDGF
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Dissolution of Fibrin Clot
  • Alteplase
  • Urokinase
  • Reteplase
  • Anistreplase
  • Tenecteplase
  • Streptokinase
  • Tranexamic acid
  • Aminocaproic acid
  • Bicine
  • Desmoteplase
  • Aprotinin
  • Copper
  • Gabexate
  • Inherited thrombophilia
PLSCR1 phospholipid scramblase 1
SCARB2 scavenger receptor class B member 2
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • Progressive myoclonic epilepsy (PME), including: Lafora disease (LBD); Unverricht-Lundborg disease (ULD); Neuronal ceroid lipofuscinoses (NCL); Type I sialidosis; Action myoclonus-renal failure syndrome (AMRF); Type III Gaucher disease (GD)
SPARC secreted protein acidic and cysteine rich
  • Platelet degranulation
  • Nuclear signaling by ERBB4
  • ECM proteoglycans
  • Scavenging by Class H Receptors
  • Calcium citrate
  • Calcium Phosphate
  • Calcium phosphate dihydrate
TFPI tissue factor pathway inhibitor
  • Extrinsic Pathway of Fibrin Clot Formation
  • IIa Recombinant Human
  • Dalteparin
  • Andexanet alfa
TGFB1 transforming growth factor beta 1
  • Platelet degranulation
  • Influenza Virus Induced Apoptosis
  • Cell surface interactions at the vascular wall
  • Molecules associated with elastic fibres
  • Downregulation of TGF-beta receptor signaling
  • Downregulation of TGF-beta receptor signaling
  • TGF-beta receptor signaling activates SMADs
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • Syndecan interactions
  • ECM proteoglycans
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • TGFBR1 KD Mutants in Cancer
  • TGFBR1 LBD Mutants in Cancer
  • Transcriptional regulation of white adipocyte differentiation
  • UCH proteinases
  • Interleukin-4 and Interleukin-13 signaling
  • RUNX3 regulates CDKN1A transcription
  • Regulation of RUNX3 expression and activity
  • RUNX3 regulates p14-ARF
  • TGFBR3 regulates TGF-beta signaling
  • Hyaluronidase (ovine)
  • Terazosin
  • Hyaluronidase (human recombinant)
  • Foreskin fibroblast (neonatal)
  • Foreskin keratinocyte (neonatal)
  • Hyaluronidase
  • Graft-versus-host disease
  • Allograft rejection
  • Camurati-Engelmann disease; Progressive diaphyseal dysplasia
TGM2 transglutaminase 2
  • Guanosine-5'-Diphosphate
  • Hexylresorcinol
TNFAIP6 TNF alpha induced protein 6
  • Neutrophil degranulation
  • Donepezil
  • Acetylsalicylic acid
  • Hyaluronic acid
TNFRSF11B TNF receptor superfamily member 11b
  • TNFs bind their physiological receptors
  • Paget's disease of bone and related disorders, including: ; Paget's disease of bone (PDB); Familial expansile osteolysis (FEO); Early-onset Paget's disease of bone (PDB2); Expansile skeletal hyperphosphatasia (ESH); Juvenile Paget's disease (JPD)
WEE2-AS1 WEE2 antisense RNA 1
WWP2 WW domain containing E3 ubiquitin protein ligase 2
  • Regulation of PTEN stability and activity
  • RHOQ GTPase cycle
  • RHOJ GTPase cycle
  • RHOU GTPase cycle
  • NOTCH3 Activation and Transmission of Signal to the Nucleus

Page 3 out of 3 pages